Photo Credit: Real Farmacy
'After considerable pressure from independent health journalists, researchers, statisticians, and some MDs, finally the World Health Organization (WHO) responded positively. Now the WHO is proposing public access to all drug trial papers.
Why is this important? Because by the time a study is completed, all the reports are often collated and edited to offer only the most glowing parts of the trial outcomes while hiding adverse event reports.'